As of December 31, 2022, a total of 44,280 adverse events were reported in Spain after vaccination with Comirnaty Original, while 770 cases corresponded to the Bivalent dose. As of that date, the vaccine developed by Pfizer/BioNTech was the most used against COVID-19 within the country, with over 67.2 million doses administered of the original version and more than seven million of the bivalent vaccine. The most common adverse events recorded with the Pfizer/BioNTech vaccine were pyrexia (fever), headache, and myalgia.
Number of adverse events reported after receiving the coronavirus (COVID-19) vaccine in Spain as of December 31, 2022, by manufacturer
Created with Highcharts 7.2.2Number of cases44,28044,28020,19320,19312,50312,5031,4511,451770770474733Pfizer/BioNTech (Original)Moderna (Original)Oxford/AstraZeneca*Janssen*Pfizer-BioNTech Bivalent(Original/Omicron BA.4-5)Moderna Bivalent (Original/Omicron BA.1)Novavax
010,00020,00030,00040,00050,000
Add this content to your personal favorites. These can be accessed from the favorites menu in the main navigation.
You have no right to use this feature.
Make sure to contact us if you are interested in scientific citation.
You can upgrade your account to enable this functionality for all statistics.
This feature is not available with your current account.Request access
Includes any kind of adverse event notified after receiving the coronavirus (COVID-19) vaccine. Adverse events are not to be interpreted as induced by the vaccine until a casual relationship is confirmed.
As of December 31, 2022, the total number of doses administered in Spain was as follows:
Learn more about how Statista can support your business.
AEMPS. (January 19, 2023). Number of adverse events reported after receiving the coronavirus (COVID-19) vaccine in Spain as of December 31, 2022, by manufacturer [Graph]. In Statista. Retrieved May 09, 2025, from https://www.statista.com/statistics/1220430/covid-19-vaccine-number-of-adverse-events-reported-in-spain-by-manufacturer/
AEMPS. "Number of adverse events reported after receiving the coronavirus (COVID-19) vaccine in Spain as of December 31, 2022, by manufacturer." Chart. January 19, 2023. Statista. Accessed May 09, 2025. https://www.statista.com/statistics/1220430/covid-19-vaccine-number-of-adverse-events-reported-in-spain-by-manufacturer/
AEMPS. (2023). Number of adverse events reported after receiving the coronavirus (COVID-19) vaccine in Spain as of December 31, 2022, by manufacturer. Statista. Statista Inc.. Accessed: May 09, 2025. https://www.statista.com/statistics/1220430/covid-19-vaccine-number-of-adverse-events-reported-in-spain-by-manufacturer/
AEMPS. "Number of Adverse Events Reported after Receiving The Coronavirus (Covid-19) Vaccine in Spain as of December 31, 2022, by Manufacturer." Statista, Statista Inc., 19 Jan 2023, https://www.statista.com/statistics/1220430/covid-19-vaccine-number-of-adverse-events-reported-in-spain-by-manufacturer/
AEMPS, Number of adverse events reported after receiving the coronavirus (COVID-19) vaccine in Spain as of December 31, 2022, by manufacturer Statista, https://www.statista.com/statistics/1220430/covid-19-vaccine-number-of-adverse-events-reported-in-spain-by-manufacturer/ (last visited May 09, 2025)
Number of adverse events reported after receiving the coronavirus (COVID-19) vaccine in Spain as of December 31, 2022, by manufacturer [Graph], AEMPS, January 19, 2023. [Online]. Available: https://www.statista.com/statistics/1220430/covid-19-vaccine-number-of-adverse-events-reported-in-spain-by-manufacturer/
Profit from additional features with an Employee Account
Please create an employee account to be able to mark statistics as favorites.
Then you can access your favorite statistics via the star in the header.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.